Assessment of LDL receptor-dependent lipid lowering therapies in patients with homozygous familial hypercholesterolemia according to functional genotype.
Saved in:
| Title: | Assessment of LDL receptor-dependent lipid lowering therapies in patients with homozygous familial hypercholesterolemia according to functional genotype. |
|---|---|
| Authors: | Mancini GBJ; Centre for Cardiovascular Innovation, Dilawri Cardiovascular Institute, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: mancini@mail.ubc.ca., Ryomoto A; Centre for Cardiovascular Innovation, Dilawri Cardiovascular Institute, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada., Ruel I; Research Institute of the McGill University Health Center, Department of Medicine, Montreal, Quebec, Canada., Iatan I; Research Institute of the McGill University Health Center, Department of Medicine, Montreal, Quebec, Canada; Centre for Heart and Lung Innovation, Division of General Internal Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Genest J; Research Institute of the McGill University Health Center, Department of Medicine, Montreal, Quebec, Canada., Raal FJ; Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Santos RD; Academic Research Organization, Hospital Israelita Albert Einstein, Sao Paulo, Brazil; Lipid Clinic, Heart Institute (InCor) University of Sao Paulo, Medical School Hospital, Sao Paulo, Brazil., Marte AP; Lipid Clinic, Heart Institute (InCor) University of Sao Paulo, Medical School Hospital, Sao Paulo, Brazil., Kennedy BA; Departments of Medicine and Biochemistry, Robarts Research Institute, University of Western Ontario, London, Ontario Canada., Brunham LR; Centre for Heart and Lung Innovation, Division of General Internal Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Gaudet D; Department of Medicine and ECOGENE-21, Université de Montreal, Chicoutimi, Québec, Canada., Larouche M; Department of Medicine and ECOGENE-21, Université de Montreal, Chicoutimi, Québec, Canada., Brisson D; Department of Medicine and ECOGENE-21, Université de Montreal, Chicoutimi, Québec, Canada., Hegele RA; Departments of Medicine and Biochemistry, Robarts Research Institute, University of Western Ontario, London, Ontario Canada. |
| Corporate Authors: | Canadian Homozygous Familial Hypercholesterolemia - HoFH Registry |
| Source: | Atherosclerosis [Atherosclerosis] 2026 Mar; Vol. 414, pp. 120646. Date of Electronic Publication: 2026 Jan 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: Ireland NLM ID: 0242543 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1484 (Electronic) Linking ISSN: 00219150 NLM ISO Abbreviation: Atherosclerosis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
